| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92d71a3e23389a3bca747290fc6464cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d610873487d2bc9668c04d7c2ec8e6c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2016-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05053685e79482335b0b1d845b53f00b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa53340d652dc7c1ea21b5ed456100a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e6ed6b30d3ca817303318561385e8be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c9b8b33aa855fa2c24b923318a3c75a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58636031436cd16fd9989c676fe50e62 |
| publicationDate |
2019-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2019015446-A1 |
| titleOfInvention |
Medicinal composition for improving prognosis after restart of patient's own heartbeat |
| abstract |
[Problem] To provide a medicinal composition that is capable of improving the prognosis after the restart of the patient's own heartbeat even after the passage of a considerably long period of time after the restart of the patient's own heartbeat. [Solution] A gaseous medicinal composition for improving the prognosis alter the restart of the patients own heartbeat, said medicinal composition being to be administered to a human subject after the passage of at least 30 minutes after the restart of the patient's own heartbeat following cardiorespiratory arrest for at least 10 minutes. The medicinal composition according to the present invention, which contains hydrogen gas, is characterized in that a group of human patients administered with the medicinal composition shows improved prognosis after the restart of the patient's own heartbeat compared with another group of human patients not administered with the medicinal composition. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11458277-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023086409-A1 |
| priorityDate |
2015-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |